Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale
ABSTRACT Objectives: The version of the Minnesota Nicotine Withdrawal Scale (MNWS) under consideration consists of nine items. No psychometric analyses of this version have been published. The objectives of this investigation were to perform a factor analysis and to further assess the psychometric p...
Gespeichert in:
Veröffentlicht in: | Current medical research and opinion 2005-05, Vol.21 (5), p.749-760 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 760 |
---|---|
container_issue | 5 |
container_start_page | 749 |
container_title | Current medical research and opinion |
container_volume | 21 |
creator | Cappelleri, Joseph C. Bushmakin, Andrew G. Baker, Christine L. Merikle, Elizabeth Olufade, Abayomi O. Gilbert, David G. |
description | ABSTRACT
Objectives: The version of the Minnesota Nicotine Withdrawal Scale (MNWS) under consideration consists of nine items. No psychometric analyses of this version have been published. The objectives of this investigation were to perform a factor analysis and to further assess the psychometric properties of the MNWS.
Research design and methods: Data came from three Phase II clinical trials on varenicline, developed for smoking cessation, in a sample of smokers. Exploratory factor analysis was used to examine the structure of the MNWS in the first completed study ( n = 626) over various time periods. The postulated factor structure was then tested in a set of confirmatory analyses conducted on two subsequent studies ( n = 627, n = 312). The proposed structure was further evaluated through construct validity and reliability analyses.
Main outcome measures: The nine items of the MNWS included the following: urge to smoke (craving); depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating; restlessness; increased appetite; difficulty going to sleep; and difficulty staying asleep.
Each item was rated by a subject on an ordinal scale from 0 (not at all) to 4 (extreme).
Results: Scree plots and rotated factor patterns from the exploratory factor analyses revealed two multi-item domains – Negative Affect with four items and Insomnia with two items – and three individual items (Craving, Restlessness, Increased Appetite). Confirmatory factor analyses supported the structure with fit indexes exceeding 0.90. The multidimensional framework of the MNWS correlated as expected with health status, depicted an expected course of withdrawal symptoms over time, predicted the sensitivity of withdrawal symptoms on subsequent cessation, and produced internal reliability estimates above 0.70.
Conclusions: Evidence is obtained to support the validity and reliability of the multidimensional structure of the nine-item MNWS. The data suggest that the MNWS has individual constructs on Negative Affect (depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating), Insomnia (difficulty going to sleep; difficulty staying asleep), Craving, Restlessness, and Increased Appetite. As such, analyzing each construct separately would strengthen the analysis of the popular MNWS. |
doi_str_mv | 10.1185/030079905X43712 |
format | Article |
fullrecord | <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_1185_030079905X43712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>851726571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-7612003c675403a3af125b53ac8aa548863f5b0b1e6492a532231a4e5259f27d3</originalsourceid><addsrcrecordid>eNp1kEtLAzEUhYMoWqtrdzK4H5vnZOJOii9QBB_gbridydjoTFKT1OK_N7WFouDqLs53DpcPoSOCTwkpxQgzjKVSWLxwJgndQgPCJct5KeU2GizTPMViD-2H8IYxoaVSu2iPCFWoUvIBenzQnxo6Y1-zONVZP--iaUyvbTDOQpe1Hnq9cP49c-0PcWes1cFFyKypXTRWZwsTp42HRcJDDZ0-QDstdEEfru8QPV9ePI2v89v7q5vx-W1ec8piLgtCMWZ1IQXHDBi0hIqJYFCXAIKXZcFaMcEToguuKAhGKSPAtaBCtVQ2bIhOVrsz7z7mOsTqzc19-jpUNFkpOBcyQaMVVHsXgtdtNfOmB_9VEVwtHVZ_HKbG8Xp2Pul1s-HX0hJwtgKMbZ3vIenpmirCV-d88mVrEyr2_7r6VZ4m-3Fag9eb7__rfgOYL5Bz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>207964457</pqid></control><display><type>article</type><title>Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale</title><source>MEDLINE</source><source>Taylor & Francis:Master (3349 titles)</source><source>Taylor & Francis Medical Library - CRKN</source><creator>Cappelleri, Joseph C. ; Bushmakin, Andrew G. ; Baker, Christine L. ; Merikle, Elizabeth ; Olufade, Abayomi O. ; Gilbert, David G.</creator><creatorcontrib>Cappelleri, Joseph C. ; Bushmakin, Andrew G. ; Baker, Christine L. ; Merikle, Elizabeth ; Olufade, Abayomi O. ; Gilbert, David G.</creatorcontrib><description>ABSTRACT
Objectives: The version of the Minnesota Nicotine Withdrawal Scale (MNWS) under consideration consists of nine items. No psychometric analyses of this version have been published. The objectives of this investigation were to perform a factor analysis and to further assess the psychometric properties of the MNWS.
Research design and methods: Data came from three Phase II clinical trials on varenicline, developed for smoking cessation, in a sample of smokers. Exploratory factor analysis was used to examine the structure of the MNWS in the first completed study ( n = 626) over various time periods. The postulated factor structure was then tested in a set of confirmatory analyses conducted on two subsequent studies ( n = 627, n = 312). The proposed structure was further evaluated through construct validity and reliability analyses.
Main outcome measures: The nine items of the MNWS included the following: urge to smoke (craving); depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating; restlessness; increased appetite; difficulty going to sleep; and difficulty staying asleep.
Each item was rated by a subject on an ordinal scale from 0 (not at all) to 4 (extreme).
Results: Scree plots and rotated factor patterns from the exploratory factor analyses revealed two multi-item domains – Negative Affect with four items and Insomnia with two items – and three individual items (Craving, Restlessness, Increased Appetite). Confirmatory factor analyses supported the structure with fit indexes exceeding 0.90. The multidimensional framework of the MNWS correlated as expected with health status, depicted an expected course of withdrawal symptoms over time, predicted the sensitivity of withdrawal symptoms on subsequent cessation, and produced internal reliability estimates above 0.70.
Conclusions: Evidence is obtained to support the validity and reliability of the multidimensional structure of the nine-item MNWS. The data suggest that the MNWS has individual constructs on Negative Affect (depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating), Insomnia (difficulty going to sleep; difficulty staying asleep), Craving, Restlessness, and Increased Appetite. As such, analyzing each construct separately would strengthen the analysis of the popular MNWS.</description><identifier>ISSN: 0300-7995</identifier><identifier>EISSN: 1473-4877</identifier><identifier>DOI: 10.1185/030079905X43712</identifier><identifier>PMID: 15969874</identifier><identifier>CODEN: CMROCX</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Benzazepines - therapeutic use ; Craving ; Factor analysis ; Factor Analysis, Statistical ; Female ; Humans ; Male ; Middle Aged ; Minnesota ; Nicotine ; Nicotinic Agonists - therapeutic use ; Psychometrics ; Psychometrics - instrumentation ; Quinoxalines - therapeutic use ; Reliability ; Reproducibility of Results ; Severity of Illness Index ; Sickness Impact Profile ; Smoking cessation ; Smoking Cessation - psychology ; Substance Withdrawal Syndrome - physiopathology ; Substance Withdrawal Syndrome - psychology ; Surveys and Questionnaires ; Tobacco Use Disorder - drug therapy ; Validity ; Varenicline ; Withdrawal scale</subject><ispartof>Current medical research and opinion, 2005-05, Vol.21 (5), p.749-760</ispartof><rights>2005 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2005</rights><rights>Copyright Librapharm May 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-7612003c675403a3af125b53ac8aa548863f5b0b1e6492a532231a4e5259f27d3</citedby><cites>FETCH-LOGICAL-c423t-7612003c675403a3af125b53ac8aa548863f5b0b1e6492a532231a4e5259f27d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1185/030079905X43712$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1185/030079905X43712$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,59646,59752,60435,60541,61220,61255,61401,61436</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15969874$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cappelleri, Joseph C.</creatorcontrib><creatorcontrib>Bushmakin, Andrew G.</creatorcontrib><creatorcontrib>Baker, Christine L.</creatorcontrib><creatorcontrib>Merikle, Elizabeth</creatorcontrib><creatorcontrib>Olufade, Abayomi O.</creatorcontrib><creatorcontrib>Gilbert, David G.</creatorcontrib><title>Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale</title><title>Current medical research and opinion</title><addtitle>Curr Med Res Opin</addtitle><description>ABSTRACT
Objectives: The version of the Minnesota Nicotine Withdrawal Scale (MNWS) under consideration consists of nine items. No psychometric analyses of this version have been published. The objectives of this investigation were to perform a factor analysis and to further assess the psychometric properties of the MNWS.
Research design and methods: Data came from three Phase II clinical trials on varenicline, developed for smoking cessation, in a sample of smokers. Exploratory factor analysis was used to examine the structure of the MNWS in the first completed study ( n = 626) over various time periods. The postulated factor structure was then tested in a set of confirmatory analyses conducted on two subsequent studies ( n = 627, n = 312). The proposed structure was further evaluated through construct validity and reliability analyses.
Main outcome measures: The nine items of the MNWS included the following: urge to smoke (craving); depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating; restlessness; increased appetite; difficulty going to sleep; and difficulty staying asleep.
Each item was rated by a subject on an ordinal scale from 0 (not at all) to 4 (extreme).
Results: Scree plots and rotated factor patterns from the exploratory factor analyses revealed two multi-item domains – Negative Affect with four items and Insomnia with two items – and three individual items (Craving, Restlessness, Increased Appetite). Confirmatory factor analyses supported the structure with fit indexes exceeding 0.90. The multidimensional framework of the MNWS correlated as expected with health status, depicted an expected course of withdrawal symptoms over time, predicted the sensitivity of withdrawal symptoms on subsequent cessation, and produced internal reliability estimates above 0.70.
Conclusions: Evidence is obtained to support the validity and reliability of the multidimensional structure of the nine-item MNWS. The data suggest that the MNWS has individual constructs on Negative Affect (depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating), Insomnia (difficulty going to sleep; difficulty staying asleep), Craving, Restlessness, and Increased Appetite. As such, analyzing each construct separately would strengthen the analysis of the popular MNWS.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Benzazepines - therapeutic use</subject><subject>Craving</subject><subject>Factor analysis</subject><subject>Factor Analysis, Statistical</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Minnesota</subject><subject>Nicotine</subject><subject>Nicotinic Agonists - therapeutic use</subject><subject>Psychometrics</subject><subject>Psychometrics - instrumentation</subject><subject>Quinoxalines - therapeutic use</subject><subject>Reliability</subject><subject>Reproducibility of Results</subject><subject>Severity of Illness Index</subject><subject>Sickness Impact Profile</subject><subject>Smoking cessation</subject><subject>Smoking Cessation - psychology</subject><subject>Substance Withdrawal Syndrome - physiopathology</subject><subject>Substance Withdrawal Syndrome - psychology</subject><subject>Surveys and Questionnaires</subject><subject>Tobacco Use Disorder - drug therapy</subject><subject>Validity</subject><subject>Varenicline</subject><subject>Withdrawal scale</subject><issn>0300-7995</issn><issn>1473-4877</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kEtLAzEUhYMoWqtrdzK4H5vnZOJOii9QBB_gbridydjoTFKT1OK_N7WFouDqLs53DpcPoSOCTwkpxQgzjKVSWLxwJgndQgPCJct5KeU2GizTPMViD-2H8IYxoaVSu2iPCFWoUvIBenzQnxo6Y1-zONVZP--iaUyvbTDOQpe1Hnq9cP49c-0PcWes1cFFyKypXTRWZwsTp42HRcJDDZ0-QDstdEEfru8QPV9ePI2v89v7q5vx-W1ec8piLgtCMWZ1IQXHDBi0hIqJYFCXAIKXZcFaMcEToguuKAhGKSPAtaBCtVQ2bIhOVrsz7z7mOsTqzc19-jpUNFkpOBcyQaMVVHsXgtdtNfOmB_9VEVwtHVZ_HKbG8Xp2Pul1s-HX0hJwtgKMbZ3vIenpmirCV-d88mVrEyr2_7r6VZ4m-3Fag9eb7__rfgOYL5Bz</recordid><startdate>200505</startdate><enddate>200505</enddate><creator>Cappelleri, Joseph C.</creator><creator>Bushmakin, Andrew G.</creator><creator>Baker, Christine L.</creator><creator>Merikle, Elizabeth</creator><creator>Olufade, Abayomi O.</creator><creator>Gilbert, David G.</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><general>Informa Healthcare</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>200505</creationdate><title>Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale</title><author>Cappelleri, Joseph C. ; Bushmakin, Andrew G. ; Baker, Christine L. ; Merikle, Elizabeth ; Olufade, Abayomi O. ; Gilbert, David G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-7612003c675403a3af125b53ac8aa548863f5b0b1e6492a532231a4e5259f27d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Benzazepines - therapeutic use</topic><topic>Craving</topic><topic>Factor analysis</topic><topic>Factor Analysis, Statistical</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Minnesota</topic><topic>Nicotine</topic><topic>Nicotinic Agonists - therapeutic use</topic><topic>Psychometrics</topic><topic>Psychometrics - instrumentation</topic><topic>Quinoxalines - therapeutic use</topic><topic>Reliability</topic><topic>Reproducibility of Results</topic><topic>Severity of Illness Index</topic><topic>Sickness Impact Profile</topic><topic>Smoking cessation</topic><topic>Smoking Cessation - psychology</topic><topic>Substance Withdrawal Syndrome - physiopathology</topic><topic>Substance Withdrawal Syndrome - psychology</topic><topic>Surveys and Questionnaires</topic><topic>Tobacco Use Disorder - drug therapy</topic><topic>Validity</topic><topic>Varenicline</topic><topic>Withdrawal scale</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cappelleri, Joseph C.</creatorcontrib><creatorcontrib>Bushmakin, Andrew G.</creatorcontrib><creatorcontrib>Baker, Christine L.</creatorcontrib><creatorcontrib>Merikle, Elizabeth</creatorcontrib><creatorcontrib>Olufade, Abayomi O.</creatorcontrib><creatorcontrib>Gilbert, David G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Current medical research and opinion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cappelleri, Joseph C.</au><au>Bushmakin, Andrew G.</au><au>Baker, Christine L.</au><au>Merikle, Elizabeth</au><au>Olufade, Abayomi O.</au><au>Gilbert, David G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale</atitle><jtitle>Current medical research and opinion</jtitle><addtitle>Curr Med Res Opin</addtitle><date>2005-05</date><risdate>2005</risdate><volume>21</volume><issue>5</issue><spage>749</spage><epage>760</epage><pages>749-760</pages><issn>0300-7995</issn><eissn>1473-4877</eissn><coden>CMROCX</coden><abstract>ABSTRACT
Objectives: The version of the Minnesota Nicotine Withdrawal Scale (MNWS) under consideration consists of nine items. No psychometric analyses of this version have been published. The objectives of this investigation were to perform a factor analysis and to further assess the psychometric properties of the MNWS.
Research design and methods: Data came from three Phase II clinical trials on varenicline, developed for smoking cessation, in a sample of smokers. Exploratory factor analysis was used to examine the structure of the MNWS in the first completed study ( n = 626) over various time periods. The postulated factor structure was then tested in a set of confirmatory analyses conducted on two subsequent studies ( n = 627, n = 312). The proposed structure was further evaluated through construct validity and reliability analyses.
Main outcome measures: The nine items of the MNWS included the following: urge to smoke (craving); depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating; restlessness; increased appetite; difficulty going to sleep; and difficulty staying asleep.
Each item was rated by a subject on an ordinal scale from 0 (not at all) to 4 (extreme).
Results: Scree plots and rotated factor patterns from the exploratory factor analyses revealed two multi-item domains – Negative Affect with four items and Insomnia with two items – and three individual items (Craving, Restlessness, Increased Appetite). Confirmatory factor analyses supported the structure with fit indexes exceeding 0.90. The multidimensional framework of the MNWS correlated as expected with health status, depicted an expected course of withdrawal symptoms over time, predicted the sensitivity of withdrawal symptoms on subsequent cessation, and produced internal reliability estimates above 0.70.
Conclusions: Evidence is obtained to support the validity and reliability of the multidimensional structure of the nine-item MNWS. The data suggest that the MNWS has individual constructs on Negative Affect (depressed mood; irritability, frustration, or anger; anxiety; difficulty concentrating), Insomnia (difficulty going to sleep; difficulty staying asleep), Craving, Restlessness, and Increased Appetite. As such, analyzing each construct separately would strengthen the analysis of the popular MNWS.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>15969874</pmid><doi>10.1185/030079905X43712</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-7995 |
ispartof | Current medical research and opinion, 2005-05, Vol.21 (5), p.749-760 |
issn | 0300-7995 1473-4877 |
language | eng |
recordid | cdi_informahealthcare_journals_10_1185_030079905X43712 |
source | MEDLINE; Taylor & Francis:Master (3349 titles); Taylor & Francis Medical Library - CRKN |
subjects | Adolescent Adult Aged Benzazepines - therapeutic use Craving Factor analysis Factor Analysis, Statistical Female Humans Male Middle Aged Minnesota Nicotine Nicotinic Agonists - therapeutic use Psychometrics Psychometrics - instrumentation Quinoxalines - therapeutic use Reliability Reproducibility of Results Severity of Illness Index Sickness Impact Profile Smoking cessation Smoking Cessation - psychology Substance Withdrawal Syndrome - physiopathology Substance Withdrawal Syndrome - psychology Surveys and Questionnaires Tobacco Use Disorder - drug therapy Validity Varenicline Withdrawal scale |
title | Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A33%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Revealing%20the%20multidimensional%20framework%20of%20the%20Minnesota%20nicotine%20withdrawal%20scale&rft.jtitle=Current%20medical%20research%20and%20opinion&rft.au=Cappelleri,%20Joseph%20C.&rft.date=2005-05&rft.volume=21&rft.issue=5&rft.spage=749&rft.epage=760&rft.pages=749-760&rft.issn=0300-7995&rft.eissn=1473-4877&rft.coden=CMROCX&rft_id=info:doi/10.1185/030079905X43712&rft_dat=%3Cproquest_infor%3E851726571%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=207964457&rft_id=info:pmid/15969874&rfr_iscdi=true |